Author

Ilan Lenga

Observed names: I Lenga, Lenga, Ilan

Institution: Lakeridge Health

Observed institutions: Alberta Health Services, St. Michael's Hospital, University Health Network, University of Alberta, University of Toronto, Queen's University, Lakeridge Health

ORCID: 0000-0001-8417-4128

Observed ORCID: 0000-0001-8417-4128

OpenAlex ID: A5018065853

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

2023 · Ron Wald, Stephane Gaudry, et al. · Intensive Care Medicine · 78

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

2022 · Sean M. Bagshaw, Ary Serpa Neto, et al. · Intensive Care Medicine · 31

Minimum urine flow rate during water deprivation: Importance of the permeability of urea in the inner medulla

1998 · Manjula Gowrishankar, Ilan Lenga, et al. · Kidney International · 29

Role of Oral Iron in the Management of Long-Term Hemodialysis Patients

2007 · Ilan Lenga, Charmaine Lok, et al. · Clinical Journal of the American Society of Nephrology · 24

A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

2022 · Fernando G. Zampieri, Bruno R. da Costa, et al. · Critical Care · 20

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis

2019 · Ilan Lenga, Wilma M. Hopman, et al. · BMC Nephrology · 11

“Can I go to Glasgow?” Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD)

2020 · Talia Gutman, Karine E Manera, et al. · Peritoneal Dialysis International · 10

Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis

2022 · Arenn Jauhal, Heather N Reich, et al. · Nephrology Dialysis Transplantation · 6

Factors associated with adverse haemodynamic events during the STARRT-AKI trial: a post-hoc secondary analysis

2025 · Yvelynne P. Kelly, Bruno R. da Costa, et al. · Critical Care · 5

Cost-Utility Analysis of Accelerated and Standard Strategies for Renal Replacement Therapy Initiation

2025 · Jeff Round, Ilke Akpinar, et al. · JAMA Network Open · 1

Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

2023 · Sean M. Bagshaw, Ary Serpa Neto, et al. · Intensive Care Medicine

Works count: 16

Citation count: 215

H-index: 7

I10-index: 7